|
Name: Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine)
Type: Stimulant
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Methiopropamine, a synthetic stimulant, was first synthesized in the 2000s. It is known for its stimulant effects and is part of a broader family of synthetic cathinones. Its history includes its recreational use and regulatory challenges.
|
|
V. Legal Information
Methiopropamine is a synthetic stimulant with effects similar to methamphetamine. It is controlled in various jurisdictions, including the United States, where it may be regulated under laws concerning new psychoactive substances. Internationally, regulations aim to prevent its misuse. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Methiopropamine (MPA) is a synthetic stimulant with effects similar to amphetamines. It increases heart rate and blood pressure. Short-term use may enhance alertness and energy, but long-term use poses risks of cardiovascular issues, psychological problems, and dependency. Overdose risks include severe agitation, cardiovascular effects, and potential death. Safe use requires cautious dosing and monitoring. Recent research explores its stimulant effects and associated health risks.  |
|
VII. Psychological Effects
Methiopropamine (MPA) is a synthetic stimulant producing euphoria, increased alertness, and enhanced focus. Immediate psychological effects include mood elevation, increased sociability, and anxiety. Long-term use can lead to dependence, anxiety disorders, and cognitive impairments. Chronic use is associated with mood swings and potential psychiatric disorders. Recent research indicates risks of severe anxiety and paranoia.
 |
|
VIII. Culture
Methiopropamine (MPA) is a synthetic stimulant similar to methamphetamine, acting as an upper. It increases alertness, energy, and euphoria. Short-term use can elevate heart rate and blood pressure, while long-term use poses risks of cardiovascular damage and psychological dependence. Overdose can cause severe agitation, hyperthermia, and cardiac arrest. Safe use is not well-established, but recreational doses are typically around 20-50 mg. Recent studies highlight significant addiction potential and limited therapeutic value. Physical signs include dilated pupils and rapid heart rate.
 |